Navigation Links
Medical Affairs Report Outlines Resource Needs for Group Success
Date:9/3/2010

CHAPEL HILL, N.C., Sept. 3 /PRNewswire/ -- The Medical Affairs function arguably plays the most critical role in a biopharmaceutical organization, with heavy responsibilities across areas such as clinical development, scientific publications, KOL development, and medical education. These areas must operate effectively for new products to succeed. Appropriate spending across these activities is one of the challenges facing the Medical Affairs function as it attempts to balance its different roles across the organization.

According to recent Best Practices, LLC research, 37 percent of Medical Affairs spending, on average, is allocated for medical/clinical research, with the top quartile of respondents spending more than 60 percent for the clinical function. Meanwhile, medical education takes up 18 percent of allocations, according to the study.

"Medical Affairs Resources, Structures and Trends" highlights trends in budget and staffing for Medical Affairs groups to help leaders in Medical Affairs effectively and efficiently meet the myriad roles of the function. The 45-page report also identifies current organizational approaches for Medical Affairs and current trends and challenge the function is facing.

Twenty-two organizations participated in this study, including: Amgen, AstraZeneca, Bayer Healthcare, BMS, Genentech, J&J Vision Care, Novartis, Novo Nordisk, Schering-Plough, Solvay, Vertex and others.

"Medical Affairs Resources, Structures & Trends" covers key topics such as:

  • Organizational Structure
  • Reporting Relationship
  • Job Level of Group Leader
  • Geographic Span
  • Budget Allocation by Medical Affairs Function
  • Percent of Budget Allocated for Outsourcing
  • Recent and Anticipated Changes in Resource Levels
  • Impact of Medical Affairs Functions on Company Success
  • Key Success Factors for Medical Affairs
  • Key Challenges for Medical Affairs

To learn more about this report, including information about the research participants, key findings and sample best practices, please download a complimentary excerpt and study overview at: http://www3.best-in-class.com/re1020.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies.  For 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.  For more information about the company, go to www.best-in-class.com.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Second Annual Medical Device Connectivity Conference & Exhibition to Focus on Connecting Medical Devices to People, Workflow and Information Systems
2. Asian Medical Markets Expert to Speak at the Wells Fargo Investor Forum
3. MedWOW Adds Comparison Tool for Shoppers Medical Equipment - Offers eBook Free to New Registrants
4. Varian Medical Systems Establishes Radiotherapy Training Center in Mumbai, India
5. Millstone Medical Outsourcing Launches New, Improved Company Website
6. Reportlinker Adds The Market for Medical Devices in Brazil, Russia, India & China
7. Invisible Bracelet Launches Nationwide Emergency Medical Notification Text Messaging Service
8. Shire Announces Support for Inflammatory Bowel Disease (IBD) Fellowships at Leading Medical Institutions Nationwide
9. Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems
10. Aethlon Medical to Present at Rodman & Renshaw Annual Global Investment Conference
11. Cape Medical Supply Named to Prestigious Inc. 5000 List of Americas Fastest Growing Private Companies for Fourth Year in a Row
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... 2017 Caris Life Sciences, a leading ... promise of precision medicine, today announced results from ... its molecular profiling approach in guiding therapeutic strategies ... plus (CGP+) with Caris Molecular Intelligence ® ... molecular level, leading to more therapeutic options and ...
(Date:9/6/2017)...  Robert G. Szewc, M.D., is recognized by Continental ... of his contributions to the Medical field.      ... the practice of Kidney and Hypertension Specialists, which specializes ... solutions. He has worked in this position since 2002, ... well as expertise in kidneys, hypertension, chronic disease and ...
(Date:9/6/2017)... Sept. 6, 2017 Eli Lilly and Company ... present new data for galcanezumab and lasmiditan, two investigational ... International Headache Society (IHC) taking place Sept. 7-10 in ... will highlight new, long-term data from an open-label study ... galcanezumab (120 mg and 240 mg) for the prevention ...
Breaking Medicine Technology:
(Date:9/25/2017)... , ... September 25, 2017 , ... ... Institute is excited to announce the next generation for LASIK in Manhattan with ... of the most technologically advanced laser systems available in the United States to ...
(Date:9/25/2017)... ... September 25, 2017 , ... Dr. Edward Hebert ... “I could not imagine doing anything else,” said Dr. Hebert. “I count my blessings ... day. The interactions with my patients is what I look forward to the most. ...
(Date:9/25/2017)... ... September 25, 2017 , ... “The ... a gripping look at the religious stand in the sensitive matter of ... and compassion. “The Ministry of Reconciliation: A Compassionate and Realistic Approach to Evangelizing ...
(Date:9/25/2017)... , ... September 25, 2017 , ... “The Majestic Unicorn”: ... the great flood. “The Majestic Unicorn” is the creation of published author, Dayna Chantel, ... small, came from far and wide to march aboard the cypress ark-vessel. Male and ...
(Date:9/25/2017)... ... September 25, 2017 , ... The trend-spotters, tastemakers, and ... maker of organic coconut-milk based super herb drinks, with the new NEXTY Gold Award ... the inaugural year for the NEXTY Gold, which is reserved for just those companies ...
Breaking Medicine News(10 mins):